2183 — Linical Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapNeutral

Annual income statement for Linical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,935	10,279	11,555	12,517	12,308
Cost of Revenue
Gross Profit	3,531	2,768	3,612	4,162	3,778
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	10,056	10,053	10,609	11,183	11,724
Operating Profit	879	226	946	1,334	583
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	808	359	1,032	1,379	660
Provision for Income Taxes
Net Income After Taxes	483	540	790	1,004	338
Net Income Before Extraordinary Items
Net Income	483	540	790	1,004	338
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	483	540	790	1,004	338
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	37.2	40.5	51.8	56.1	33.6
Dividends per Share
Special Dividends per Share